Plasma lipid peroxidation and total antioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease

West African Journal of Medicine

Volumn 28, Issue 2, 2009, Pages 87-91

  Ogunro, P S ^a   Balogun, W O ^a   Fadero, F F ^a   Idogun, E S ^b   Oninla, S O ^a   Elemile, P O ^a   Eziyi, A K ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Cholesterol; Coronary heart disease; Hypertension; Lipid peroxidation; Total antioxidant

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; FREE RADICAL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NIGERIA;

EID: 69249181754     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: 10.4314/wajm.v28i2.48430     Document Type: Article

References (29)

1. Okezie IA, Harparkash K, Haliwell B. Oxygen free radicals and human diseases. J Roy Soc Health 1991; 34: 171-177.
2. Halliwell B. Free radicals, reactive oxygen species, and humandisease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989; 70: 737-757. (Pubitemid 20022141)
3. Parthasarathy S, Fong LG, Steinberg D. Oxidative modification of low density lipoprotein and atherosclerosis: concepts and consequences. In: Lipid Peroxidation in Biological Systems, edited by A. Sevanian. Champaign, IL: Am Oil Chemists' Sot., 1987, p. 225-235.
4. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc NatZ Acad Sci USA 1989; 86: 1372-1376. (Pubitemid 19061548)
5. Steinbrecher UP, Parthasarathy S, Leake DS. et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc NatZ Acad Sci USA 1984; 81: 3883-3887. (Pubitemid 14087823)
6. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radical BioZ Med 1990; 9: 155-168. (Pubitemid 20270685)
7. Steinberg, D. Parthasarathy S Carew T E. et al. Beyond cholesterol: modifications of low-density lipo-protein that increase its atherogenicity. N. EngZ. J Med. 1989; 320: 915-924.
8. Triau JE, Meydani SM and Schaefer E J. Oxidized low density lipoprotein stimulates prostacyclin production by adult vascular endothelial cells. AtheroscZerosis 1988; 8: 810-818. (Pubitemid 19005369)
9. Morel DW, and Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J.Lipid Res. 1989; 30: 1827-1834.
10. Parthasarathy S, Young SG, Witztum JL, et al. Probucol inhibits oxidative modification of low density lipoprotein. J. CZin. Invest.1986; 77: 641-644
11. Daugherty A, Zwiefel B S, Sobel B E.et al. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1988; 8: 768-777.
12. Regnstrom J, Nilsson J, Tornvall P et al. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-1186.
13. Chisolm GM. Antioxidants and atherosclerosis: a current assessment. Gin. Cardiol. 12, SuppZ. 1991; 1: 1-25-1-30.
14. Halliwell B, Free radicals and Antioxidants: A Personal View. J of Nutrition Review 1994; 52(6): 253-265. (Pubitemid 24308025)
15. Taylor GO, Bamigboye AE. Serum cholesterol & disease in Nigeria. AMJ. Clin Butri. 1979; 32: 2540-2545.
16. Adedeji OO, Onitiri AC. Plasma lipids in Nigeria hypertensives. Afri J Med Sci 1990; 19: 281-284
17. Fredickson DS, Levy RL, Lees RS. Estimation of serum Total cholesterol. N Engl J Med 1967; 276: 146-156.
18. Trinder P. A method of estimation of serum Triglyceride. Am Clin Biochemistry 1969; 6: 24-27.
19. Gordon T. Estimation of High Density Lipoprotein. Amer J Med 1997; 62: 707-208.
20. Friedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative untracentrifuge. Clin Chem 1972; 18: 499-509.
21. Carl A B, Edward R A. Reference rang of analysis in: Tietz Textbook of Clinical Chemistry 3rd edition. W.B. Saunders Company. 1999; 687.
22. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43. (Pubitemid 9055456)
23. McLemore J L, Beeley P, Thorton K et al Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV. Am J Clin Pathol 1998; 109: 268-273.
24. Ogunnowo PO, Odesanmi WO, Andy JJ. Coronary artery pathology of 111 consecutive Nigerians. Trans R Soc Trop Med Hyg. 1986; 80: 923-926
25. Prasad K and Kalra J. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999; 99: 1355-1362 (Pubitemid 29129922)
26. Das S, Vasisht S, Das SN el al. Correlation between total anti-oxidant status and lipid peroxidation in hypercholesterolemia. Current Science. 2000; 78: 486-487.
27. Enstrom, JE, Kanim, LE, Klein, MA. Vitamin C intake and mortality among a sample of the United States Population. Epidemiology 1992; 3: 194-202.
28. Schwertner, HA, Jackson, WG, Tolan, G Association of low serum bilirubin with increased risk of coronary artery disease. Clin.Chem. 1994; 40: 18-23.
29. Gey, KG., Puska, P, Jordon, P, et al. (1991) Inverse correlation between Vitamin E and mortality from ischemic heart disease in cross cultural epidemiology. Am J Clin Nutr. 1991; 53: S326-334.